PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 28, 2026JAMA1 citations

Geographic Shifts in Early-Stage Biopharmaceutical Innovation

View Full Paper
SKSo-Yeon KangYJYunan Ji

Key Points

  • The research aims to analyze changes in the geographic origins of early-stage biopharmaceutical innovations from 2015 to 2025.
  • Examine early-stage biopharmaceutical development programs globally
  • Analyze data on country of origin from 2015 to 2025
  • Identified significant shifts in the locations of biopharmaceutical innovations
  • Highlighting emerging countries in biopharmaceutical development
  • Documented decreases in traditional biotech hubs' contributions

Abstract

This study examines changes from 2015 through 2025 in the country of origin of early-stage biopharmaceutical development programs worldwide.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kang et al. (2026) studied this question.

synapsesocial.com/papers/69c772818bbfbc51511e3049https://doi.org/10.1001/jama.2026.1962
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Biopharmaceutical pipeline funded by venture capital firms, 2014 to 20242024 · 13 citations
  2. 2The Rise of Drug Innovation in China — Implications for Patient Access in the United States and Globally2025 · 9 citations
  3. 3Analysis of China-to-West pharmaceutical licensing deals in 20242025 · 4 citations
  4. 4Research and development financing models for new biopharmaceuticals in the United States2025 · 3 citations
  5. 5The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation2025 · 14 citations